• 1
    Bertagna, X., Guignat, L., Groussin, L. et al. (2009) Cushing's disease. Best Practice and Research Clinical Endocrinology and Metabolism, 23, 607623.
  • 2
    Newell-Price, J., Bertagna, X., Grossman, A.B. et al. (2006) Cushing's syndrome. The Lancet, 367, 16051617.
  • 3
    Clayton, R.N., Raskauskiene, D., Reulen, R.C. et al. (2011) Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. Journal of Clinical Endocrinology and Metabolism, 96, 632642.
  • 4
    Webb, S.M., Badia, X., Barahona, M.J. et al. (2008) Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. European Journal of Endocrinology, 158, 623630.
  • 5
    Etxabe, J. & Vazquez, J.A. (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology, 40, 479484.
  • 6
    Dekkers, O.M., Biermasz, N.R., Pereira, A.M. et al. (2007) Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism, 92, 976981.
  • 7
    Swearingen, B., Biller, B.M., Barker, F.G. et al. (1999) Long-term mortality after transsphenoidal surgery for Cushing disease. Annals of Internal Medicine, 130, 821824.
  • 8
    Boscaro, M. & Arnaldi, G. (2009) Approach to the patient with possible Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 94, 31213131.
  • 9
    Nieman, L.K., Biller, B.M., Findling, J.W. et al. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 93, 15261540.
  • 10
    Elamin, M.B., Murad, M.H., Mullan, R. et al. (2008) Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. Journal of Clinical Endocrinology and Metabolism, 93, 15531562.
  • 11
    Pivonello, R., De Martino, M.C., Cappabianca, P. et al. (2009) The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. Journal of Clinical Endocrinology and Metabolism, 94, 223230.
  • 12
    Godbout, A., Manavela, M.P., Danilowicz, K. et al. (2010) Cabergoline monotherapy in the long-term treatment of Cushing's disease. European Journal of Endocrinology, 163, 709716.
  • 13
    Colao, A., Petersenn, S., Newell-Price, J. et al. (2012) A 12-month Phase 3 study of pasireotide in Cushing's disease. The New England Journal of Medicine, 366, 914924.
  • 14
    Oldfield, E.H., Doppman, J.L., Nieman, L.K. et al. (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. The New England Journal of Medicine, 325, 897905.
  • 15
    Malerbi, D.A., Mendonca, B.B., Liberman, B. et al. (1993) The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology, 38, 463472.
  • 16
    Turpeinen, U., Markkanen, H., Valimaki, M. et al. (1997) Determination of urinary free cortisol by HPLC. Clinical Chemistry, 43, 13861391.
  • 17
    Quan, H. & Shih, W.J. (1996) Assessing reproducibility by the within-subject coefficient of variation with random effects models. Biometrics, 52, 11951203.
  • 18
    Besemer, F., Pereira, A.M. & Smit, J.W. (2011) Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse. The Netherlands Journal of Medicine, 69, 318323.
  • 19
    Invitti, C., Pecori Giraldi, F., Dubini, A. et al. (1991) Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome. Acta Endocrinologica (Copenhagen), 125, 2832.
  • 20
    Vierhapper, H., Kiss, A., Nowotny, P. et al. (1990) Metabolism of cortisol in anorexia nervosa. Acta Endocrinologica (Copenhagen), 122, 753758.
  • 21
    Viardot, A., Huber, P., Puder, J.J. et al. (2005) Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. Journal of Clinical Endocrinology and Metabolism, 90, 57305736.
  • 22
    Starkman, M.N., Giordani, B., Berent, S. et al. (2001) Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine, 63, 985993.
  • 23
    Sonino, N., Fava, G.A., Raffi, A.R. et al. (1998) Clinical correlates of major depression in Cushing's disease. Psychopathology, 31, 302306.
  • 24
    Bakker, R.C., Gallas, P.R., Romijn, J.A. et al. (1998) Cushing's syndrome complicated by multiple opportunistic infections. Journal of Endocrinological Investigation, 21, 329333.
  • 25
    Graham, B.S. & Tucker, W.S. Jr (1984) Opportunistic infections in endogenous Cushing's syndrome. Annals of Internal Medicine, 101, 334338.
  • 26
    Del Dotto, P. & Bonuccelli, U. (2003) Clinical pharmacokinetics of cabergoline. Clinical Pharmacokinetics, 42, 633645.
  • 27
    Pecori Giraldi, F., Moro, M. & Cavagnini, F. (2003) Gender-related differences in the presentation and course of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 88, 15541558.
  • 28
    Findling, J.W., Pinkstaff, S.M., Shaker, J.L. et al. (1998) Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. The Endocrinologist, 8, 5154.
  • 29
    Meikle, A.W., Findling, J., Kushnir, M.M. et al. (2003) Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. Journal of Clinical Endocrinology and Metabolism, 88, 35213524.